Stay updated with breaking news from T Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers at Children's Hospital of Philadelphia (CHOP) and the University of California, Los Angeles (UCLA) have developed a computational platform capable of discovering tumor antigens derived from alternative RNA splicing, expanding the pool of cancer immunotherapy targets.
Through a recent platform demonstration project, LabGenius’ machine learning-driven lead optimisation capability delivered dozens of novel T-cell engagers with best-in-class killing selectivity.
Not st. eligius, st. elsewhere -- a place you wouldn't want to send your mother-in-law. >> when it first came on, it was actually promoted as "hill street" in a hospital. >> you give your patients the wrong antibiotics. you don't know what medications they're on. you write the worst progress notes. you're pathetic. pathetic. >> phil! >> what? >> dr. moray needs you right away. >> i'm sorry. >> "st. elsewhere" broke every rule there was and then built some new rules. >> bobby, the blood bank called a little while ago. they ran a routine panel on that pint of blood. t-cell count was off. >> they...
Researchers conducted a phase I clinical trial of a personalized mRNA neoantigen vaccine.
MyJournals.org - Science - 'Human T-cell lymphotropic virus type 1 (HTLV-1) proposed vaccines: a systematic review of preclinical and clinical studies' (BMC Infectious Diseases)